NCT00345098 - A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder | Biotech Hunter

Enrollment

704

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Depressive DisorderMajor Depression

Interventions

DRUG

SR58611A

Trial Locations (13)

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Sofia

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Belgrade

Sanofi-Aventis Administrative Office, Bratislava

Sanofi-Aventis Administrative Office, Midrand